SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 141 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.88 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,270,815 | +15.8% | 54,966 | +28.9% | 0.00% | 0.0% |
| Q2 2023 | $1,097,296 | 0.0% | 42,630 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $1,097,296 | +56.7% | 42,630 | +58.4% | 0.00% | – |
| Q4 2022 | $700,137 | -99.9% | 26,918 | +12.1% | 0.00% | – |
| Q3 2022 | $685,319,000 | +75.0% | 24,021 | +51.0% | 0.00% | – |
| Q2 2022 | $391,655,000 | -66.8% | 15,908 | -23.9% | 0.00% | -100.0% |
| Q1 2022 | $1,180,330,000 | -8.9% | 20,913 | 0.0% | 0.00% | – |
| Q4 2021 | $1,296,188,000 | -2.3% | 20,913 | 0.0% | 0.00% | -100.0% |
| Q3 2021 | $1,326,721,000 | -23.0% | 20,913 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $1,723,440,000 | +20.8% | 20,913 | +7.8% | 0.00% | 0.0% |
| Q1 2021 | $1,427,258,000 | +26.2% | 19,400 | +24.4% | 0.00% | 0.0% |
| Q4 2020 | $1,131,312,000 | +128.2% | 15,600 | +50.0% | 0.00% | – |
| Q3 2020 | $495,768,000 | – | 10,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 7,281,307 | $347,100,000 | 32.35% |
| BVF INC/IL | 2,053,991 | $97,914,000 | 5.33% |
| Samsara BioCapital, LLC | 398,017 | $18,973,000 | 5.29% |
| Orbimed Advisors | 7,406,307 | $353,059,000 | 4.44% |
| Consonance Capital Management LP | 602,732 | $28,732,000 | 3.50% |
| Boxer Capital, LLC | 2,075,905 | $98,958,000 | 3.42% |
| Perceptive Advisors | 3,481,148 | $165,946,000 | 2.42% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,234,262 | $58,837,000 | 1.43% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 974,915 | $46,474,000 | 0.95% |
| HighVista Strategies LLC | 11,477 | $547,000 | 0.40% |